These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3129843)

  • 1. Nicardipine enhances the effect of cyclosporine A on T lymphocyte activation in vitro.
    van Eendenburg JP; Brisson E; Klatzmann D; Gluckman JC
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):245-52. PubMed ID: 3129843
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of drugs used in anticoagulation therapy on T lymphocyte activation in vitro. I. Heparin inhibits activation by soluble antigen or allogeneic cells but not by phytohaemagglutinin.
    Bruserud O; Lundin K
    J Clin Lab Immunol; 1987 Jul; 23(3):117-21. PubMed ID: 3499516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of cyclosporines A and G on activation of an autoimmune T cell line.
    Caspi RR; McAllister CG; Gery I; Borel J; Hiestand P; Nussenblatt RB
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):110-4. PubMed ID: 2966473
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial immunosuppressive effect of combined use of FK 506 and cyclosporine assessed by proliferative responses of cloned human T cells.
    Matsuura T; Shinohara Y; Hara Y; Imanishi M; Nishioka T; Kunikata S; Kanda H; Akiyama T; Kurita T
    Transplant Proc; 1991 Dec; 23(6):2931-2. PubMed ID: 1721316
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
    Kay JE; Benzie CR
    Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A does not prevent expression of biologically active IL 2 receptors in vitro.
    Bloemena E; van Oers MH; Weinreich S; Yong SL; Schellekens PT
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):131-5. PubMed ID: 3129838
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy.
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):202-6. PubMed ID: 3129840
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine-induced enhancement of interleukin 1 receptor expression by PHA-stimulated lymphocytes.
    Degiannis D; Stein S; Czarnecki M; Raskova J; Raska K
    Transplantation; 1990 Dec; 50(6):1074-6. PubMed ID: 2147793
    [No Abstract]   [Full Text] [Related]  

  • 13. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
    Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
    J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.
    Ryffel B
    Pharmacol Rev; 1990 Sep; 41(3):407-22. PubMed ID: 2185492
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of docosahexaenoic and eicosapentaenoic acids on in vitro-induced human lymphoproliferative responses.
    Khalfoun B; Lacord M; Bardos P; Lebranchu Y
    Transplant Proc; 1996 Oct; 28(5):2913-4. PubMed ID: 8908121
    [No Abstract]   [Full Text] [Related]  

  • 18. Early supernatants of mitogen-stimulated mononuclear cells promote long-term IL-2-dependent growth of human T lymphocytes.
    Siwicki JK; Steffen JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):109-17. PubMed ID: 8915514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.
    Calder VL; Bellamy AS; Owen S; Lewis C; Rudge P; Davison AN; Feldmann M
    Clin Exp Immunol; 1987 Dec; 70(3):570-7. PubMed ID: 3124996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.
    Freed BM; Stevens C; Zhang G; Rosano TG; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):233-9. PubMed ID: 3284070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.